Treg Directed Therapy for Autoimmune Disorders Summit 2018
Evvnt Promotion / evvnt
Archive
22.05.2018 - 24.05.2018Westin Boston Waterfront, 425 Summer Street, 02210 Boston, USA
8:00 am to 4:00 pm
Conference themes This is your first and only opportunity to listen to the most advanced clinical case studies from Nektar Therapeutics and Amgen which explore the use of IL-2 to enhance the expansion and activation of the Treg cells. Delve deeper with expert insights from Roche and ILTOO Pharma to understand how IL-2 at low doses could selectively stimulate Treg cells.
URLs: Brochure:https://go.evvnt.com/197029-1?pid=4832
Inquiries: https://go.evvnt.com/197029-2?pid=4832
Professional congress organizer (PCO) Hanson Wade
Notes Chris Haqq, Kevin Gorski, Nadia Tchao, David Wraith, Andrew Scharenberg, Simrit Parmar, Robert Plenge, Stephen Miller, Todd Brusko, Jeremie Mariau, Laurence Turka, Jason Fontenot, Leonard Dragone